With the first 1,000 days of life presenting a unique window of opportunity for long-term positive effects on a baby’s health, Dr Kai Lin Ek and Dr Dietrich Rein, scientific marketing managers, BASF nutrition & health, show how the right start can provide the best defence against developing allergic diseases.
The Omegavie DHA algae quality silver by Polaris is fish-free and natural. Made from sustainable sources of microalgae, the omega-3 oil is suitable for vegetarians and vegans.
Omega-3 is used both in the dietary supplement and food markets. DHA omega-3 contributes to the maintenance of normal vision, as well as regular brain and heart function. Applications for food include dairy products such as milk and butter, as well as bread and cereals.
The oil is non-GMO, free from allergens, does not contain toxins, and is five times more stable than standard algal oil. This results in shelf-life optimisation and preservation of its nutritional, flavour, aroma and mouthfeel qualities.
Co-microencapsulation of probiotic bacteria with omega-3 rich tuna oil will improve its survival and intestinal adhering ability, which can be applied to nutraceuticals.
Omega-3 is one of the most commonly taken supplements, though the market seems to be moving away from the conventional fish oil. With krill as one of the rising sources of omega-3, what new innovations and applications are there for it? By Becky Wright, marketing director, Aker BioMarine
Lampertheim, Germany: BASF is implementing a series of measures within the nutrition and health division to strengthen the competitiveness of its performance products segment.
The division bundles the company’s products and solutions for human and animal nutrition, the flavour and fragrance industry, as well as the pharmaceutical industry.
The company is adjusting its product portfolio in order to better meet changing consumer needs and regional demands. In Asia, BASF is building a citral plant with its partner Petronas to meet the growing demand of customers in the flavour and fragrance industry in the region.
The first plants of the complex are expected to come on stream in 2016. At the same time, the company will focus its production in the growing market of omega-3 fatty acids on the attractive market segment for highly concentrated omega-3 fatty acids and plans to sell the Norwegian Brattvåg site. The company produces low concentrated omega-3 fatty acids at this site.
Marketing, sales and administration will be better adjusted to regional market dynamics. A global team responsible for marketing and innovation will in future support the development of customer-oriented products and solutions as well as faster market launches of new products. The company aims to accelerate the innovation cycle of products for its customers through strategic partnerships.
Due to the planned measures about 260 positions in production, marketing and administration will be reduced globally by end of 2015. Consultations with the responsible employee representatives will be conducted.